ARVO family of journals
The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include over 11,500 eye and vision researchers from more than 75 countries. The association advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. ARVO publishes three highly respected, peer-reviewed, open access journals.
Donald C. Hood, PhD, Editor-in-Chief
IOVS, published online several times a month, includes original contributions that emphasize clinical and laboratory hypothesis-based research with statistically valid results that clearly advance the fields of ophthalmic and vision research. IOVS de-emphasizes purely descriptive research.
2016 Impact Factor for IOVS: 3.303
This places IOVS 11th among 59 ophthalmology journals according to the 2017 Release of Journal Citation Reports. Source: 2016 Web of Science Data.
Andrew B. Watson, PhD, Editor-in-chief
The Journal of Vision is devoted to all aspects of visual function in humans and other organisms. It explores topics such as spatial vision, perception, low vision, color vision and more, spanning the fields of neuroscience, psychology and psychophysics.
2016 Impact Factor for JOV: 2.671
This places JOV 16th among 59 ophthalmology journals according to the 2017 Release of Journal Citation Reports. Source: 2016 Web of Science Data.
Marco Zarbin, MD, PhD, FARVO, Editor-in-Chief
TVST emphasizes multidisciplinary research that bridges the gap between basic research and clinical care. The journal covers a broad spectrum of work, including: applications of stem cell technology, development of new animal models of human diseases, tissue bioengineering, chemical engineering to improve virus-based gene delivery, nanotechnology for drug delivery, design and synthesis of artificial extracellular matrices, development of a true microsurgical operating environment, refining data analysis algorithms to improve in vivo imaging technology, results of Phase 1 clinical trials, reverse translational research, and more.
2016 Impact Factor for TVST: 2.221
This places TVST 24th among 59 ophthalmology journals according to the 2017 Release of Journal Citation Reports. Source: 2016 Web of Science Data.
Jon Mallett, Director of Journals
Debbie Chin, Journals Manager
Marco Stoutamire, Editorial Coordinator, IOVS
Kiyah Morrison, Editorial Coordinator, JOV and TVST
- 1801 Rockville Pike, Suite 400
- Rockville, MD 20852
- E-mail: firstname.lastname@example.org
- Phone: +18.104.22.16820
- Fax: +1.240.221.0370